This Post Was Syndicated Under License Via QuoteMedia
TORONTO, Aug. 1, 2019 /PRNewswire/ – Canopy Rivers Inc. (“Canopy Rivers” or the “Company“) (TSXV: RIV) (OTC: CNPOF) is pleased to announce that its portfolio company Radicle Medical Marijuana Inc. (“Radicle“) has received approval from Health Canada for its production facility expansion project. This approval effectively doubles Radicle’s production footprint, significantly increasing its capacity to 6,000 kilograms per year.
“We are thrilled with the continued growth happening at Radicle,” said Narbe Alexandrian, President and CEO of Canopy Rivers. “The cannabis industry is showing many similarities to ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.